Paddy K.C. Janssen

687 total citations
35 papers, 398 citations indexed

About

Paddy K.C. Janssen is a scholar working on Psychiatry and Mental health, Endocrinology, Diabetes and Metabolism and Pharmacology. According to data from OpenAlex, Paddy K.C. Janssen has authored 35 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Psychiatry and Mental health, 9 papers in Endocrinology, Diabetes and Metabolism and 8 papers in Pharmacology. Recurrent topics in Paddy K.C. Janssen's work include Sexual function and dysfunction studies (15 papers), Antibiotics Pharmacokinetics and Efficacy (8 papers) and Sexuality, Behavior, and Technology (8 papers). Paddy K.C. Janssen is often cited by papers focused on Sexual function and dysfunction studies (15 papers), Antibiotics Pharmacokinetics and Efficacy (8 papers) and Sexuality, Behavior, and Technology (8 papers). Paddy K.C. Janssen collaborates with scholars based in Netherlands, United States and China. Paddy K.C. Janssen's co-authors include Marcel D. Waldinger, Berend Olivier, Aeilko H. Zwinderman, Daan J. Touw, János Réthelyi, Steven C. Bakker, Frank de Vries, RHN van Schaik, Jos L.M.L. le Noble and Andrea M. Burden and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Anesthesiology.

In The Last Decade

Paddy K.C. Janssen

34 papers receiving 380 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Paddy K.C. Janssen 262 164 113 78 72 35 398
Nannan Thirumavalavan 176 0.7× 80 0.5× 162 1.4× 77 1.0× 90 1.3× 83 562
Bülent Semerci 247 0.9× 138 0.8× 105 0.9× 113 1.4× 78 1.1× 38 507
Sarah Cipriani 238 0.9× 99 0.6× 353 3.1× 49 0.6× 76 1.1× 30 722
Bruno Giammusso 372 1.4× 130 0.8× 192 1.7× 152 1.9× 73 1.0× 33 563
Tung‐Chin Hsieh 181 0.7× 48 0.3× 181 1.6× 97 1.2× 112 1.6× 43 494
A. J. Riley 252 1.0× 113 0.7× 141 1.2× 59 0.8× 27 0.4× 18 350
K.-P. Jünemann 172 0.7× 57 0.3× 115 1.0× 210 2.7× 22 0.3× 61 445
Luigi Barbieri 527 2.0× 126 0.8× 284 2.5× 272 3.5× 61 0.8× 20 622
Paulo Roberto Sogari 521 2.0× 102 0.6× 363 3.2× 307 3.9× 84 1.2× 11 740
Karl Mock 333 1.3× 79 0.5× 305 2.7× 134 1.7× 36 0.5× 10 425

Countries citing papers authored by Paddy K.C. Janssen

Since Specialization
Citations

This map shows the geographic impact of Paddy K.C. Janssen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paddy K.C. Janssen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paddy K.C. Janssen more than expected).

Fields of papers citing papers by Paddy K.C. Janssen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paddy K.C. Janssen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paddy K.C. Janssen. The network helps show where Paddy K.C. Janssen may publish in the future.

Co-authorship network of co-authors of Paddy K.C. Janssen

This figure shows the co-authorship network connecting the top 25 collaborators of Paddy K.C. Janssen. A scholar is included among the top collaborators of Paddy K.C. Janssen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paddy K.C. Janssen. Paddy K.C. Janssen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pistorius, Arthur M. A., Rob ter Heine, Tim Frenzel, et al.. (2025). Population pharmacokinetics and optimized dosing of cefuroxime in critically ill patients. British Journal of Clinical Pharmacology. 91(9). 2755–2761.
2.
Punt, Nieko, et al.. (2023). Target attainment and population pharmacokinetics of flucloxacillin in critically ill patients: a multicenter study. Critical Care. 27(1). 82–82. 6 indexed citations
3.
Janssen, Paddy K.C., et al.. (2023). The rs6296 polymorphism in the 5-HT1b receptor in Dutch men with lifelong premature ejaculation: a genetic case-control association study. The Journal of Sexual Medicine. 21(2). 122–128. 1 indexed citations
4.
Janssen, Paddy K.C., et al.. (2023). Possible Pathophysiological Roles of Neurotransmitter Systems in Men With Lifelong Premature Ejaculation: Protocol for a Scoping Review. JMIR Research Protocols. 12. e41301–e41301. 1 indexed citations
5.
Bergh, Joop P. van den, et al.. (2021). The use of oral glucocorticoids and the risk of major osteoporotic fracture in patients with myasthenia gravis. Osteoporosis International. 33(3). 649–658. 7 indexed citations
6.
Rooij, Kim van, Jos Bloemers, James G. Pfaus, et al.. (2021). A survival of the fittest strategy for the selection of genotypes by which drug responders and non-responders can be predicted in small groups. PLoS ONE. 16(3). e0246828–e0246828. 3 indexed citations
7.
Vries, Frank de, et al.. (2021). His452Tyr 5-HT2A polymorphism and intravaginal ejaculation latency time in Dutch men with lifelong premature ejaculation. International Journal of Impotence Research. 35(2). 103–106. 5 indexed citations
8.
Foudraine, Norbert A., et al.. (2020). Liquid Chromatography-Tandem Mass Spectrometry to Monitor Unbound and Total Ceftriaxone in Serum of Critically Ill Patients. PubMed. 16(4). 341–349. 3 indexed citations
9.
10.
11.
Klop, C., et al.. (2018). Association between use of antidepressants or benzodiazepines and the risk of subsequent fracture among those aged 65+ in the Netherlands. Osteoporosis International. 29(11). 2477–2485. 8 indexed citations
12.
Burden, Andrea M., Sander de Kort, Pauline A. J. Vissers, et al.. (2017). No Decreased Risk of Gastrointestinal Cancers in Users of Metformin in The Netherlands; A Time-Varying Analysis of Metformin Exposure. Cancer Prevention Research. 10(5). 290–297. 27 indexed citations
13.
Burden, Andrea M., Sander de Kort, Myrthe P. P. van Herk‐Sukel, et al.. (2017). Impact of detection bias on the risk of gastrointestinal cancer and its subsites in type 2 diabetes mellitus. European Journal of Cancer. 79. 61–71. 14 indexed citations
14.
Janssen, Paddy K.C., et al.. (2016). Cyclic Vomiting Syndrome: An Update Illustrated by a Case Report. The Primary Care Companion For CNS Disorders. 18(3). 3 indexed citations
15.
Janssen, Paddy K.C., RHN van Schaik, Aeilko H. Zwinderman, Berend Olivier, & Marcel D. Waldinger. (2014). The 5-HT1A receptor C(1019)G polymorphism influences the intravaginal ejaculation latency time in Dutch Caucasian men with lifelong premature ejaculation. Pharmacology Biochemistry and Behavior. 121. 184–188. 34 indexed citations
16.
Janssen, Paddy K.C., et al.. (2014). The 5-HT2C receptor gene Cys23Ser polymorphism influences the intravaginal ejaculation latency time in Dutch Caucasian men with lifelong premature ejaculation. Asian Journal of Andrology. 16(4). 607–607. 26 indexed citations
17.
18.
Heijden, Frank van der, et al.. (2013). Effects of maternal psychotropic drug dosage on birth outcomes. Neuropsychiatric Disease and Treatment. 10. 13–13. 6 indexed citations
19.
Janssen, Paddy K.C., Steven C. Bakker, János Réthelyi, et al.. (2008). Serotonin Transporter Promoter Region (5-HTTLPR) Polymorphism is Associated with the Intravaginal Ejaculation Latency Time in Dutch Men with Lifelong Premature Ejaculation. The Journal of Sexual Medicine. 6(1). 276–284. 134 indexed citations
20.
Janssen, Paddy K.C., et al.. (2006). Die Deziduose - eine seltene lebensbedrohliche Komplikation in der Schwangerschaft. Geburtshilfe und Frauenheilkunde. 66(8). 774–777. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nannan Thirumavalavan Breakdown of academic impact, for papers by Bülent Semerci Breakdown of academic impact, for papers by Sarah Cipriani Breakdown of academic impact, for papers by Bruno Giammusso Breakdown of academic impact, for papers by Tung‐Chin Hsieh Breakdown of academic impact, for papers by A. J. Riley Breakdown of academic impact, for papers by K.-P. Jünemann Breakdown of academic impact, for papers by Luigi Barbieri Breakdown of academic impact, for papers by Paulo Roberto Sogari Breakdown of academic impact, for papers by Karl Mock
Rankless by CCL
2026